Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Chem Pharm Bull (Tokyo) ; 45(5): 842-8, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9178521

RESUMEN

Cyproheptadine is a drug that shows high affinity for type 2 (5-HT2) receptors. We studied a series of compounds obtained by modification of the tricyclic system of Cyp (dibenzocycloheptadiene): 2f (thioxanthene), 2g (xanthene), 2h (dihydrodibenzocycloheptadiene), 2j (diphenyl), 2i (fluorene), and 3b (phenylmethyl). Their activities at the rat cerebral cortex 5-HT2A receptor were (pKi +/- S.E.M.): 8.80 +/- 0.11 (Cyp), 8.60 +/- 0.07 (2f), 8.40 +/- 0.02 (2g), 8.05 +/- 0.03 (2h), 7.87 +/- 0.12 (2j), 6.70 +/- 0.02 (2i) and 6.45 +/- 0.02 (3b); those at the rat stomach fundus 5-HT2B receptor (pA2 +/- S.E.M.) were: 9.14 +/- 0.25 (Cyp), 8.49 +/- 0.07 (2f), 7.58 +/- 0.58 (2g), 7.02 +/- 0.14 (2h), 6.07 +/- 0.20 (2j), and undetectable (2i, 3b): and those at the pig choroidal plexus 5-HT2C receptor (pKi +/- S.E.M.) were: 8.71 +/- 0.08 (Cyp), 8.68 +/- 0.01 (2f), 8.58 +/- 0.20 (2g), 7.95 +/- 0.05 (2h), 7.57 +/- 0.04 (2j), 6.98 +/- 0.04 (2i) and 6.63 +/- 0.20 (3b). The slopes did not differ significantly from unity. The compounds exhibited the same order of activities at every type of receptor, and the most active molecules presented certain steric (butterfly conformation of the tricyclic system) and electrostatic (proton affinity on the top of the central rings) patterns. It is concluded that the activity of cyproheptadine derivatives at 5-HT2 receptors is related to these molecular features, which make feasible a common disposition to interact with all three 5-HT2 subtypes.


Asunto(s)
Ciproheptadina/análogos & derivados , Ciproheptadina/síntesis química , Receptores de Serotonina/efectos de los fármacos , Antagonistas de la Serotonina/síntesis química , Animales , Unión Competitiva/efectos de los fármacos , Corteza Cerebral/metabolismo , Plexo Coroideo/efectos de los fármacos , Plexo Coroideo/metabolismo , Ciproheptadina/farmacología , Ergolinas/metabolismo , Fundus Gástrico/efectos de los fármacos , Técnicas In Vitro , Ketanserina/metabolismo , Cinética , Masculino , Modelos Moleculares , Ratas , Ratas Sprague-Dawley , Antagonistas de la Serotonina/química , Antagonistas de la Serotonina/farmacología , Relación Estructura-Actividad , Porcinos
2.
J Pharm Sci ; 82(11): 1090-3, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8289119

RESUMEN

A series of cyproheptadine related compounds was synthesized and tested pharmacologically. In comparison with cyproheptadine, these compounds do not have a central ring and some contain groups other than N-methyl. Synthesis was carried out with low-valent titanium to generate the exocyclic double bond. The serotoninergic activity of the compounds was determined by standard determination of pA2 (-log of the motor concentration of antagonist required to maintain a constant response when concentration of agonist is doubled) for the inhibition of serotonin-induced contractions in rat stomach fundus. Two of the nitrogen-containing compounds were active, but their activities were lower than that of cyproheptadine. Structure-activity relationships were studied by Mulliken net charges, molecular electrostatic potentials, and conformational analysis; activities are better correlated with electrostatic potentials than with net charges. The decrease in potency of the open cyproheptadine analogues may be due to "dilution" of the active conformer as the result of their conformational flexibility.


Asunto(s)
Ciproheptadina/análogos & derivados , Antagonistas de la Serotonina/síntesis química , Animales , Ciproheptadina/síntesis química , Ciproheptadina/farmacología , Masculino , Conformación Molecular , Ratas , Ratas Sprague-Dawley , Antagonistas de la Serotonina/farmacología , Relación Estructura-Actividad
3.
J Comput Aided Mol Des ; 7(3): 337-47, 1993 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8377028

RESUMEN

MEPSIM is a computational system which allows an integrated computation, analysis, and comparison of molecular electrostatic potential (MEP) distributions. It includes several modules. Module MEPPLA supplies MEP values for the points of a grid defined on a plane which is specified by a set of three points. The results of this program can easily be converted into MEP maps using third-parties graphical software. Module MEPMIN allows to find automatically the MEP minima of a molecular system. It supplies the cartesian coordinates of these minima, their values, and all the geometrical relationships between them (distances, angles, and dihedral angles). Module MEPCOMP computes a similarity coefficient between the MEP distributions of two molecules and finds their relative position that maximizes the similarity. Module MEPCONF performs the same process as MEPCOMP, considering not only the relative position of both molecules but also a conformational degree of freedom of one of them. The most recently developed module, MEPPAR, is another modification of MEPCOMP in order to compute the MEP similarity between two molecules, but only taking into account a particular plane. The latter module is particularly useful to compare MEP distributions generated by pi systems of aromatic rings. MEPSIM can use several wavefunction computation approaches to obtain MEP distributions. MEPSIM has a menu type interface to simplify the following tasks: creation of input files from output files of external programs (GAUSSIAN and AMPAC/MOPAC), setting the parameters for the current computation, and submitting jobs to the batch queues of the computer. MEPSIM has been coded in FORTRAN and its current version runs on VMS/VAX computers.


Asunto(s)
Electroquímica/estadística & datos numéricos , Programas Informáticos , Diseño de Fármacos , Estructura Molecular
4.
J Pharm Sci ; 82(5): 513-7, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8360829

RESUMEN

The antiserotoninergic activity at the serotonin receptor subtype 2 (5-HT2) of seven new 2-aminoethylbenzocyclanones was determined with respect to serotonin-induced contractions in rat aorta and compared with that of ketanserine (pA2 = 8.87). Competitive antagonism was observed in six compounds (6.72 < or = pA2 < or = 8.12). Three-dimensional structures and molecular electrostatic potential distributions of ketanserine and 2-aminoethylbenzocyclanones were analyzed. Several molecular features correlated with the rank of antiserotoninergic activity. In the case of the cyclanone fragment, the rank of activity was associated with the degree of planarity of the bicyclic system. The steric and electrostatic effects due to the loss of planarity were analyzed. In the case of the amino moiety, activity was associated with a particular spatial pattern defined by the amino nitrogen, the aromatic system, and molecular electrostatic potential minima generated by the oxygen atom.


Asunto(s)
Butirofenonas/síntesis química , Cetonas/síntesis química , Músculo Liso Vascular/efectos de los fármacos , Piperidinas/síntesis química , Antagonistas de la Serotonina/síntesis química , Animales , Aorta Torácica/efectos de los fármacos , Butirofenonas/farmacología , Técnicas In Vitro , Ketanserina/farmacología , Cetonas/farmacología , Conformación Molecular , Contracción Muscular/efectos de los fármacos , Piperidinas/farmacología , Ratas , Ratas Sprague-Dawley , Serotonina/farmacología , Antagonistas de la Serotonina/farmacología , Relación Estructura-Actividad
5.
Mol Pharmacol ; 43(2): 191-9, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8429824

RESUMEN

The inhibitory effect of 44 quinolone antibacterials and derivatives (common structure, 4-oxoquinoline-3-carboxylic acid) on cytochrome P450 isoform CYP1A2 activity was tested using human liver microsomes and caffeine 3-demethylation as a specific test system for this enzyme. By direct comparison of molecules differing structurally in only one position, the following structure-activity relationships were found. 3'-Oxo derivatives had a reduced or similar activity and M1 metabolites (cleavage of piperazinyl substituent) had a greater inhibitory activity, compared with the parent molecule. Alkylation of the 7-piperazinyl substituent resulted in a reduced inhibitory potency. Naphthyridines with an unsubstituted piperazinyl group at position 7 displayed a greater inhibitory potency than did corresponding quinoline derivatives. Derivatives with a fluorine substitution at position 8 had only a minor effect. Molecular modeling studies with inhibitors and caffeine showed that it is possible to explain the potency of the quinolones to inhibit CYP1A2 on a molecular level. The keto group, the carboxylate group, and the core nitrogen at position 1 are likely to be the most important groups for binding to the active site of CYP1A2, because the molecular electrostatic potential of all inhibitors is very similar to that of caffeine in these regions. The presence of a piperazinyl substituent, however, seems to be no prerequisite for inhibitory potency. Finally, an equation to estimate the potency to inhibit CYP1A2 was developed by quantitative structure-activity relationship analysis.


Asunto(s)
Antiinfecciosos/farmacología , Inhibidores Enzimáticos del Citocromo P-450 , Oxidorreductasas N-Desmetilantes/antagonistas & inhibidores , 4-Quinolonas , Antiinfecciosos/química , Antiinfecciosos/metabolismo , Citocromo P-450 CYP1A2 , Humanos , Técnicas In Vitro , Modelos Químicos , Modelos Moleculares , Unión Proteica , Solubilidad , Relación Estructura-Actividad
6.
J Comput Aided Mol Des ; 5(4): 371-80, 1991 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1665509

RESUMEN

A new computer program has been developed to automatically obtain the relative position of two molecules in which the similarity between molecular electrostatic-potential distributions is greatest. These distributions are considered in a volume around the molecules, and the similarity is measured by the Spearman rank coefficient. The program has been tested using several pairs of molecules: water vs. water; phenylethylamine and phenylpropylamine vs. benzylamine; and methotrexate vs. dihydrofolic acid.


Asunto(s)
Electroquímica , Preparaciones Farmacéuticas/química , Programas Informáticos , Bencilaminas/química , Ácido Fólico/análogos & derivados , Ácido Fólico/química , Metotrexato/química , Preparaciones Farmacéuticas/metabolismo , Fenetilaminas/química , Teoría Cuántica , Receptores de Superficie Celular/metabolismo , Termodinámica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA